Johnson & Johnson To Pay More Than $1.6 Billion To Resolve Healthcare Fraud Allegations

Monday, November 4, 2013

Tennessee will receive more than $12 million as part of a multistate and federal agreement resolving allegations pharmaceutical manufacturer Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., used deceptive marketing tactics. Specifically, the parties will pay $1.6 billion to resolve civil and criminal allegations of unlawful marketing practices to promote the sales of their atypical antipsychotic drugs, Risperdal and Invega. 

J&J and Janssen will pay in excess of $1.2 billion to the states and the federal government to resolve four qui tam, or whistleblower, lawsuits filed in the U.S. District Court for the Eastern District of Pennsylvania under the provisions of the federal False Claims Act and similar state False Claims statutes. In addition, Janssen Pharmaceuticals, Inc. will plead guilty in federal court to a criminal misdemeanor charge of misbranding Risperdal in violation of the Food, Drug, and Cosmetic Act.  As part of the criminal plea, Janssen has agreed to pay an additional $400 million in criminal fines and forfeitures.

“We applaud the cooperative work of the states and federal government to stop drug companies from illegally marketing potentially dangerous drugs to the public,” Tennessee Attorney General Bob Cooper said.  “The public needs to be able to trust those responsible for their health and well-being, and that includes drug manufacturers and those who prescribe medications.” 

J & J and Janssen allegedly promoted, marketed and introduced Risperdal and Invega into interstate commerce for uses not approved by the Food and Drug Administration and for uses that were not medically indicated.  Once the FDA approves a drug as safe and effective, a manufacturer cannot market or promote a drug for an “off-label” or other use not identified in the FDA-approved product label.  The states contend that during the period Jan. 1, 1999 through Dec. 31, 2005, the companies promoted Risperdal for off-label uses and made false and misleading statements about the safety and efficacy of Risperdal.

The states additionally allege J&J and Janssen paid illegal kickbacks to health care professionals and long-term care pharmacy providers to induce them to promote or prescribe Risperdal to children, adolescents and the elderly when there was no FDA approval for Risperdal use in these patient populations. The states further contend that from Jan. 1, 2007 through Dec. 31, 2009, the companies promoted Invega for off-label uses and made false and misleading statements about the safety and efficacy of Invega.  The manufacturers’ alleged unlawful conduct caused false and/or fraudulent claims to be submitted to or caused purchases by government funded health care programs, including the state Medicaid programs. 

As part of the global resolution, the companies will enter into a Corporate Integrity Agreement with the U.S. Department of Health and Human Services, Office of the Inspector General, which will monitor the company’s future marketing practices.

A team from the National Association of Medicaid Fraud Control Units worked with the federal government on the investigation and conducted the settlement negotiations with the pharmaceutical manufacturers on behalf of the states.  Team members included representatives from the Offices of the Attorneys General for the states of New York, Massachusetts, Ohio and California.

Erlanger Offers Classes And Events For July 4-10

Erlanger offers online childbirth education class.  The online class is an easy-to-understand interactive program that includes more than 70 videos, animated illustrations, downloadable PDF files, review quizzes and information specific to Erlanger East and Erlanger Baroness birthing services.  By choosing the online childbirth program, participants will have access to ... (click for more)

CHI Memorial Presents 2016 Southeast Regional Urology Symposium

CHI Memorial Medical Education Committee and CHI Memorial Medical Group will present the 2016 Southeast Regional Urology Symposium on Saturday, August 27, at The Chattanoogan from  8:15 a.m. – 12:15 p.m.   Attendees can earn 3.5 continuing medical education (CME) credits at the symposium.  C. Lee Jackson, M.D., Jeffrey K. Mullins, M.D. and P. Edward Henson, M.D. ... (click for more)

Legendary Lady Vol Basketball Coach Pat Summitt Dies At Age 64

Pat Summitt , legendary Lady Vol basketball coach, mentor and mother-figure to her players; a revered ambassador for her university and state; a trailblazer for women; and a role model for people all over the world passed away early Tuesday in Knoxville at the age of 64. The UT athletic department wrote: "Born Patricia Sue Head on June 14, 1952 in Clarksville, Tn., she arrived ... (click for more)

Teen Shot Multiple Times On 4th Avenue; 2nd Youth Shot Twice On Pinewood Avenue

A teen was shot multiple times on 4th Avenue on Monday night. The victim was 19-year-old JaMarcus Davis. A second teen, 18-year-old Jaylain Ballard, was shot twice early Tuesday morning on Pinewood Avenue. In the first incident, Chattanooga Police responded at 7:20 p.m. to the area of the 2600 block of 4th Avenue on the report of shots fired. Police did not locate ... (click for more)

General Bell: Chattanooga Needs The Coolidge Medal Of Honor Heritage Center - And Response (4)

I'm pleased and indeed compelled to let you know a bit more about the exciting and most honorable "Charles H. Coolidge Medal of Honor Heritage Center" planned for Coolidge Park.     Here's what the Heritage Center will be:  It will be a fitting capstone for Chattanooga's Coolidge Park on Northshore in downtown Chattanooga.  While this exceptional Chattanooga ... (click for more)

Roy Exum: Pat Summitt’s Dash

In 1996 a woman named Linda Ellis wrote one of life’s most beautiful poems. Called “The Dash,” its first two verses read like this: “I read of a man who stood to speak at the funeral of a friend. He referred to the dates on the tombstone from the beginning…to the end. “He noted that first came the date of birth and spoke the following date with tears, but he said what ... (click for more)